ADAP - Adaptimmune Therapeutics plc Stock Trading

Adaptimmune Therapeutics plc(NASDAQ: ADAP) stock trading, description, contact, officers and directors.

About Adaptimmune Therapeutics plc

Not available

Stock Information

Adaptimmune Therapeutics plc Company Name:

ADAP Stock Symbol:

NASDAQ Market:

Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...

ADAP - Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day

- SPEARHEAD-1 enrolment on track; planning to launch ADP-A2M4 in 2022 in the US for people with synovial sarcoma - - Next registration directed trial initiating with ADP-A2M4CD8 in 1H 2021 for patients with gastroesophageal cancers - - Efficacy with SPEAR T-cells in multiple solid...
ADAP - Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS

- Data support confidence in SPEARHEAD-1 as a registrational trial - - Projected to complete recruitment of all patients in Q1 2021 - - Median duration of response was 28 weeks with ongoing responses beyond 72 weeks in two patients; median overall survival has not been r...
ADAP - Adaptimmune to Host Virtual Investor Day on Friday, November 20th

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will host a virtual Investor Day on November 20, 2020 at 8AM EST/ 1PM GMT. A lin...